Raymond James Financial
BMY icon

Raymond James Financial’s Bristol-Myers Squibb BMY Stock Holding History

Raymond James Financial’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,000
Closed -$105K – 5413
2026
Q1 		$105K Hold
2,000
– – ﹤0.01% 5027
2025
Q4 		$96K Buy
+2,000
New +$96.2K ﹤0.01% 4932

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Raymond James Financial's BMY Position: Q2 2026 in Review

Raymond James Financial reduced its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, selling an estimated $25.9M and leaving 3,469,260 shares worth $200M. The position accounts for 0.05% of the portfolio, ranked #310.

Raymond James Financial first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $337M in Q1 2025. 2,530 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Raymond James Financial held 3,469,260 shares of Bristol-Myers Squibb worth $200M as of Q2 2026.
  • Raymond James Financial sold 451,875 Bristol-Myers Squibb shares in Q2 2026, an estimated $25.9M.
  • Bristol-Myers Squibb made up 0.05% of Raymond James Financial's portfolio in Q2 2026, its #310 holding.
  • Raymond James Financial first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Bristol-Myers Squibb position peaked at $337M in Q1 2025.
  • 2,530 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.